Susquehanna International Group, LLP Enanta Pharmaceuticals Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$10.08 - $17.46 $621,502 - $1.08 Million	-61,657 Reduced 77.4%	18,005 $314,000
Q4 2023 Feb 14, 2024	SELL	$8.18 - $10.78 $72,744 - $95,866	-8,893 Reduced 10.04%	79,662 $749,000
Q3 2023 Nov 14, 2023	BUY	$11.09 - $22.13 $844,248 - $1.68 Million	76,127 Added 612.54%	88,555 $989,000
Q2 2023 Aug 11, 2023	SELL	$20.68 - $39.85 $545,083 - $1.05 Million	-26,358 Reduced 67.96%	12,428 $265,000
Q1 2023 May 16, 2023	BUY	$38.82 - $54.59 $1.18 Million - $1.65 Million	30,293 Added 356.68%	38,786 $1.57 Million
Q4 2022 Feb 14, 2023	SELL	$40.77 - $53.73 $591,776 - $779,890	-14,515 Reduced 63.09%	8,493 $395,000
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $874,773 - $1.29 Million	18,115 Added 370.22%	23,008 $1.19 Million
Q2 2022 Aug 15, 2022	SELL	$38.13 - $76.93 $394,416 - $795,763	-10,344 Reduced 67.89%	4,893 $231,000
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $455,711 - $602,440	-8,129 Reduced 34.79%	15,237 $1.09 Million
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $600,274 - $971,071	9,973 Added 74.46%	23,366 $1.75 Million
Q3 2021 Nov 15, 2021	SELL	$41.02 - $58.65 $141,888 - $202,870	-3,459 Reduced 20.53%	13,393 $761,000
Q2 2021 Aug 11, 2021	SELL	$43.76 - $53.11 $177,228 - $215,095	-4,050 Reduced 19.38%	16,852 $742,000
Q1 2021 May 17, 2021	SELL	$41.69 - $54.95 $234,839 - $309,533	-5,633 Reduced 21.23%	20,902 $1.03 Million
Q4 2020 Feb 16, 2021	BUY	$41.16 - $47.47 $800,068 - $922,721	19,438 Added 273.89%	26,535 $1.12 Million
Q2 2020 Aug 14, 2020	SELL	$46.37 - $57.58 $312,626 - $388,204	-6,742 Reduced 48.72%	7,097 $356,000
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $394,075 - $607,476	-9,798 Reduced 41.45%	13,839 $712,000
Q3 2019 Nov 14, 2019	SELL	$60.08 - $88.17 $2.58 Million - $3.79 Million	-42,984 Reduced 64.52%	23,637 $1.42 Million
Q2 2019 Aug 16, 2019	BUY	$81.3 - $97.35 $434,873 - $520,725	5,349 Added 8.73%	66,621 $5.62 Million
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $4.25 Million - $5.09 Million	52,279 Added 581.33%	61,272 $5.17 Million
Q2 2018 Aug 14, 2018	BUY	$81.85 - $120.51 $78,330 - $115,328	957 Added 11.91%	8,993 $1.04 Million
Q1 2018 May 15, 2018	BUY	$57.91 - $92.15 $465,364 - $740,517	8,036 New	8,036 $650,000

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$19.7 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$18.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$17.3 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$14 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$10.3 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account